验证fractalkine受体作为标,并确定针对2型糖尿病的药物发现候选者
1Department of Biotechnology, Babasaheb Bhimrao Ambedkar University, Lucknow, Uttar Pradesh, India.
Journal of cellular biochemistry
|December 19, 2023
概括
研究人员确定了一种潜在的新药物ZINC000032506419,用于治疗2型糖尿病. 这种化合物向于弗拉克塔尔金受体 (CX3CR1) 系统,该系统对胰岛素产生至关重要,并且在糖尿病中经常受到损害.
科学领域:
- 内分泌学和新陈代谢学
- 计算生物学 计算生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 2型糖尿病 (T2DM) 的特点是胰岛素失调,影响小岛贝塔细胞功能.
- 压素受体 (CX3CR1) 系统在调节胰岛素产生方面发挥着关键作用,但其表达因高脂肪饮食,肥胖和衰老等因素而减少.
- CX3CL1/CX3CR1复合体是一个潜在的治疗点,因为降低水平可能会导致与T2DM相关的β细胞功能障碍.
研究的目的:
- 在T2DM患者中研究CX3CR1的差异表达.
- 为了确定针对T2DM治疗的CX3CR1受体的潜在治疗化合物.
主要方法:
- 分析了使用基因表达综合数据库对T2DM患者的CX3CR1基因表达数据.
- 通过同质模型生成CX3CR1的3D结构,以识别潜在的药物结合口袋.
- 从ZINC15数据库对CX3CR1结合口袋进行了选69300万种类似药物的分子.
- 进行了50 ns的分子动力学模拟,以评估蛋白质-连接体复合物的稳定性.
主要成果:
- 确定了三种与CX3CR1结合口袋具有高结合亲和力的化合物.
- ZINC000032506419在已识别的化合物中显示出最稳定和最有前途的相互作用.
- 该研究强调了针对CX3CR1系统用于T2DM治疗的潜力.
结论:
- 鉴定的化合物ZINC000032506419显示出作为T2DM治疗剂的显著前景.
- 这项研究开辟了开发新药的途径,通过向CX3CR1通路来对抗T2DM和相关的代谢障碍.
相关概念视频
01:24Glucagon-like Receptor Agonists
327
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
327
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
01:28Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K